The invention relates to compounds of formula (I), useful for treating disorders mediated by the 5-hydroxytryptamine (serotonin) receptor IB (5-HT1B), e.g. vascular disorders, cancer and CNS disorders. The invention also provides methods of treating such disorders, and compounds and compositions etc. for their treatment.
这项发明涉及到式(I)的化合物,用于治疗通过5-羟
色胺(
血清素)受体IB(5-HT1B)介导的疾病,例如血管疾病、癌症和中枢神经系统疾病。该发明还提供了治疗这些疾病的方法,以及用于治疗的化合物和组合物等。